Âé¶¹´«Ã½
author
Subscribe
Digital
Print
August 13, 2026
Subscribe
Digital
Print
Yen
Foreign residents
Takaichi
Latest News
Home Delivery
JAPAN
Politics
Society
Crime & Legal
Science & Health
Explainer
History
WORLD
Politics
Crime & Legal
Science & Health
Society
ASIA PACIFIC
Politics
Crime & Legal
Science & Health
Society
BUSINESS
Companies
Economy
Markets
Tech
SPORTS
Sumo
Soccer
Baseball
Basketball
Tennis
Olympics
More sports
OPINION
Editorials
Commentary
Geoeconomic Briefing
Environment
CLIMATE CHANGE
Energy
SUSTAINABILITY
WILDLIFE
EARTH SCIENCE
LIFE
Travel
Digital
Food & Drink
Style & Design
Language
Lifestyle
CULTURE
Film
Books
Music
Art
TV & Streaming
Stage
Entertainment news
COMMUNITY
Voices
Issues
How-tos
Our Lives
My Account
My Bookmarks
Logout
Subscribe for more access
Meta
John Lauerman
BUSINESS
/
Companies
Dec 14, 2022
Takeda to pay up to $6 billion for Nimbus immune-therapy drug
After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.
WORLD
Mar 12, 2022
WHO exploring when and how to declare end of COVID emergency
Such a declaration would be not just a meaningful symbolic step, and would add momentum to the rollback of many pandemic-era public health policies.
WORLD
May 6, 2021
Vaccines work on this India variant. Experts fret about the next.
As infections surge by more than 300,000 cases for 14 straight days, India¡¯s limited ability to track new mutations emerging from its outbreak is a growing concern for scientists.
WORLD
/
Science & Health
Apr 14, 2021
Vaccine blood-clot side effect puts focus on immune reaction
Health officials are exploring whether and how an immune reaction may occur in people who have received vaccines made by AstraZeneca and Johnson & Johnson.
WORLD
/
Science & Health
Dec 21, 2020
Vaccines don¡¯t mean we¡¯ll see the last of COVID-19, experts warn
Even with the latest technologies, money and might behind the unprecedented global drive to knock out COVID-19, the disease is unlikely to be eliminated any time soon.
ASIA PACIFIC
/
FOCUS
Feb 24, 2020
As pandemic looms, world¡¯s top disease fighter engages Xi in delicate quest for cooperation
Tedros Adhanom Ghebreyesus has perhaps the most thankless job in global public health. As director-general of the World Health Organization, the former Ethiopian health minister is racing against time to prevent a dangerous new coronavirus in China from precipitating a worldwide pandemic.
BUSINESS
Oct 27, 2018
Trump springs globalist surprise with medicare drug-pricing plan
A drug-pricing plan unveiled by the Trump administration has put the U.S. on a path toward policies like those in Europe, where governments use tight cost controls.
BUSINESS
/
Companies
Mar 29, 2018
Takeda shares slide amid $50 billion takeover bid for Shire
Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ?5.3 trillion), which would be the Japanese company¡¯s biggest takeover ever.
WHAT¡¯S TRENDING
Editors' Picks
Gut bacteria may be behind many of Âé¶¹´«Ã½ colorectal cancer cases
¡®Total whiplash¡¯: Foreign residents react to Âé¶¹´«Ã½ changing permanent residency rules
She is Russia¡¯s richest woman. Her business empire is going up in flames.
Severe tropical storm Chan-hom makes landfall near Tokyo
What Âé¶¹´«Ã½ language rules for permanent residency should look like
Where do foreign residents in Japan want to die?
¡®Total whiplash¡¯: Foreign residents react to Âé¶¹´«Ã½ changing permanent residency rules
As Âé¶¹´«Ã½ concrete jungles sizzle, urban forestry offers an all-natural fix
Âé¶¹´«Ã½ brewers experiment with a secret ingredient: music
As countries ban social media for children, Japan mulls a different approach
Podcast
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯
Longform
What Kumamoto revealed about Âé¶¹´«Ã½ earthquake readiness
By
Alex K.T. Martin
SUSTAINABLE JAPAN
SPECIAL SUPPLEMENTS
Sponsored contents planned and edited by JT Media Enterprise Division.
SUPPLEMENTS BINDER